Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

Sònia Pernas, Miguel Martín, Peter A. Kaufman, Marta Gil-Martín, P. Gómez Pardo, Sara López‐Tarruella, Luís Manso, Eva Ciruelos, José Alejandro Pérez Fidalgo, Cristina Hernándo,

The Lancet Oncology · 2018 · 137 citations · 20 references

Concepts

References

20